KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Current Taxes (2020 - 2025)

Historic Current Taxes for Biolife Solutions (BLFS) over the last 6 years, with Q3 2025 value amounting to $3.7 million.

  • Biolife Solutions' Current Taxes fell 1539.88% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 1539.88%. This contributed to the annual value of $4.3 million for FY2024, which is 327.27% down from last year.
  • According to the latest figures from Q3 2025, Biolife Solutions' Current Taxes is $3.7 million, which was down 1539.88% from $3.6 million recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' Current Taxes registered a high of $5.5 million during Q3 2023, and its lowest value of $49000.0 during Q2 2021.
  • Its 5-year average for Current Taxes is $3.5 million, with a median of $3.9 million in 2025.
  • Its Current Taxes has fluctuated over the past 5 years, first surged by 703061.22% in 2022, then tumbled by 2717.33% in 2025.
  • Over the past 5 years, Biolife Solutions' Current Taxes (Quarter) stood at $2.6 million in 2021, then soared by 60.21% to $4.2 million in 2022, then rose by 6.0% to $4.4 million in 2023, then dropped by 3.27% to $4.3 million in 2024, then dropped by 13.51% to $3.7 million in 2025.
  • Its Current Taxes was $3.7 million in Q3 2025, compared to $3.6 million in Q2 2025 and $3.9 million in Q1 2025.